Supplemental material
Open access
1,656
Views
1
CrossRef citations to date
0
Altmetric
Original Research
A randomized, double-blind, 3-arm, parallel study assessing the pharmacokinetics, safety, tolerability and immunogenicity of AVT04, an ustekinumab candidate biosimilar, in healthy adults
Christopher Wynnea New Zealand Clinical Research, Christchurch, New ZealandView further author information
, Paul Hamiltonb New Zealand Clinical Research, Auckland, New ZealandView further author information
, Kristi McLendonc Nucleus Network Pty Ltd, Herston, AustraliaView further author information
, Heimo Stroissnigd Alvotech Germany GmbH, Jülich, GermanyView further author information
, Matthew Smithe Alvotech Swiss AG, Zürich, SwitzerlandView further author information
, Paul Duijzingse Alvotech Swiss AG, Zürich, SwitzerlandView further author information
, Ruth Ruffieuxe Alvotech Swiss AG, Zürich, SwitzerlandView further author information
, Hendrik Ottod Alvotech Germany GmbH, Jülich, GermanyView further author information
, Abid Sattarf Alvotech UK Ltd, London, UKView further author information
, Halimu N. Haliduolad Alvotech Germany GmbH, Jülich, GermanyView further author information
, Steffen Leutzd Alvotech Germany GmbH, Jülich, GermanyView further author information
& Fausto Bertie Alvotech Swiss AG, Zürich, SwitzerlandCorrespondence[email protected]
View further author information
show allView further author information
Pages 417-427
|
Received 29 Mar 2023, Accepted 15 May 2023, Published online: 23 May 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.